Impact of Obesity on Short- and Intermediate-Term Outcomes in Inflammatory Bowel Diseases: Pooled Analysis of Placebo Arms of Infliximab Clinical Trials.
Impact of Obesity on Short- and Intermediate-Term Outcomes in Inflammatory Bowel Diseases:'Pooled analysis of placebo from the Infliximab clinical trials.